Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial
Robert C. Welsh(University of Alberta), Sanjit S. Jolly(Population Health Research Institute), Brandi Meeks(Population Health Research Institute), Vladimír Džavík(University Health Network), Warren J. Cantor(University of Toronto), Goran Stanković(University of Belgrade), Fei Yuan(Population Health Research Institute), Shahar Lavi(London Health Sciences Centre), Saško Kedev, Robinder S. Sidhu(University of Alberta), Raúl Moreno(Hospital Universitario La Paz), John A. Cairns
Cited by 28
Related Papers
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
Canadian atrial fibrillation anticoaguiation (CAFA) study
|Journal of the American College of Cardiology|1991|1.1k
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT
|The Lancet|1997|958
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
|New England Journal of Medicine|2019|945
Complete Revascularization with Multivessel PCI for Myocardial Infarction
|New England Journal of Medicine|2019|926